One-time gene therapy could end lifelong transfusions for rare blood disease

Thanks to in-utero blood transfusion technology, what was once a fatal diagnosis in the womb can now result in live births. However, this medical advancement created a new challenge: a growing ...
Rheumatology Advisor

Allogeneic Transfusion Rates Decline in RA Joint Surgery, Though Risks Persist

The rate of allogeneic blood transfusion has decreased in patients with RA receiving LEJR, though transfusion remains associated with postoperative complications.
Medical Xpress

Underused blood conservation technique can reduce odds of needing transfusion during heart surgery by 27%

A University of Oklahoma study published Sept. 3 in JAMA Surgery reports that acute normovolemic hemodilution (ANH)—a blood-saving method in which a patient's blood is collected before going on ...

Gene Therapy Could End Lifelong Transfusions For Rare Blood Disorder

A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the ...